With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

The S&P 500 Index ( $SPX) ( SPY) today is down -0.41%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is down -0.43%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is down -0.35%. June E-mini S&P futures ...

AbbVie ABBV stock has gained 16.1% so far this year compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

AbbVie’s stock is climbing like your caffeine intake before a deadline, gaining traction despite a 0.60% dip over the past ...

AbbVie, Thermo Fisher Scientific, and Moderna are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks represent shares of companies that focus on ...

Shares of AbbVie Inc. ABBV slid 1.55% to $206.27 Tuesday, on what proved to be an all-around mixed trading session for the ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the SPDR S&P Dividend ETF (SDY), a passively managed exchange traded fund launched on 11/08/2005.

The general mood among these heavyweight investors is divided, with 43% leaning bullish and 21% bearish. Among these notable ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...